Invesco
TNYA icon

Invesco’s Tenaya Therapeutics TNYA Stock Holding History

Invesco’s Portfolio TNYA Stock Details TNYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$262K Buy
354,862
+216,856
+157% +$165K ﹤0.01% 3486
2026
Q1 		$95.6K Buy
+138,006
New +$102K ﹤0.01% 3629
2025
Q2 		– Sell
-12,209
Closed -$6.96K – 3874
2025
Q1 		$6.96K Sell
12,209
-667
-5% -$658 ﹤0.01% 3761
2024
Q4 		$18.4K Buy
12,876
+1,704
+15% +$3.82K ﹤0.01% 3741
2024
Q3 		$21.6K Sell
11,172
-676
-6% -$1.91K ﹤0.01% 3740
2024
Q2 		$36.7K Sell
11,848
-78
-0.7% -$322 ﹤0.01% 3848
2024
Q1 		$62.4K Sell
11,926
-793
-6% -$3.79K ﹤0.01% 3788
2023
Q4 		$41.2K Buy
+12,719
New +$27.5K ﹤0.01% 3761
2023
Q3 		– Sell
-469,753
Closed -$2.76M – 3913
2023
Q2 		$2.76M Buy
+469,753
New +$2.73M ﹤0.01% 2526

Other funds holding TNYA

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EAM
Empery Asset Management New York $86.5M AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
BGM
Burkehill Global Management New York $2.77B AUM 65.75% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Invesco's TNYA Position: Q2 2026 in Review

Invesco increased its Tenaya Therapeutics (TNYA) stake by 157% in Q2 2026, buying an estimated $165K and bringing the position to 354,862 shares worth $262K. The position accounts for ﹤0.01% of the portfolio, ranked #3486.

Invesco first reported a position in TNYA in Q2 2023 and has held it in 9 quarters since. The position peaked at $2.76M in Q2 2023. 101 funds tracked by Wall St. Rank hold TNYA as of Q2 2026.

  • Invesco held 354,862 shares of Tenaya Therapeutics worth $262K as of Q2 2026.
  • Invesco bought 216,856 Tenaya Therapeutics shares in Q2 2026, an estimated $165K.
  • Tenaya Therapeutics made up ﹤0.01% of Invesco's portfolio in Q2 2026, its #3486 holding.
  • Invesco first reported a position in Tenaya Therapeutics in Q2 2023 and has held it in 9 quarters since.
  • Invesco's Tenaya Therapeutics position peaked at $2.76M in Q2 2023.
  • 101 funds tracked by Wall St. Rank held Tenaya Therapeutics as of Q2 2026.

Based on Invesco's 13F filing for Q2 2026, filed 14 Aug 2026.